Related by context. All words. (Click for frequent words.) 65 Prognostic Index 62 Symptom Checklist 62 Functional Assessment 61 pain subscale 61 Assessment Questionnaire 61 Symptom Scale 61 Risk Stratification 60 Symptom Score 60 Symptom Severity 60 Main Outcome Measure 60 Severity Index 60 Impressions Improvement 60 Severity Score 59 Exacerbation 59 Orthostatic Hypotension 59 Hepatic Encephalopathy 59 Chemotherapy Induced 59 Main Outcome Measures 59 Peripheral Arterial 59 Assessment Scale 58 Stress Incontinence 58 Brief Pain 58 Ocular Surface Disease 58 Placebo Controlled Trial 58 Distress Scale 58 Treatment Outcome 58 Fungal Infections 58 Abnormal Involuntary Movement 58 Virus Infection 58 Dyspnea 58 Contrast Enhancement 58 Thrombotic 58 Treated Patients 57 Differential Diagnosis 57 albumin excretion rate 57 Rating Scale BPRS 57 Hypercholesterolemia 57 Scale PANSS 57 Rating Scale 57 Double Blind Randomized 57 Invasive Fungal Infections 57 Functioning GAF 57 Bacteremia 57 Score TOS 57 Significantly Improves 57 Anxiety Scale 57 IND Application 57 Health Assessment Questionnaire 57 Package Insert 56 Paroxysmal 56 Scale Revised 56 Abdominal Pain 56 Treating Chronic 56 Subscale 56 Conjugate 56 Diastolic Heart Failure 56 bronchial hyperresponsiveness 56 Nocturia 56 MSLT 56 Endocrine Therapy 56 bronchopulmonary 56 Prostatic 56 Ascites 56 Evaluable 56 Respiratory Symptoms 56 Study Demonstrates 56 #-# Full Text 56 Obsessive Compulsive Scale 56 NIH CPSI 56 Allergic Rhinitis 56 Clinical Evaluation 56 Bioavailability 56 Neurocognitive 56 Fracture Risk 56 Prophylactic Treatment 56 Efficacy Trial 55 IRLS 55 Significantly Reduces 55 Erectile Function 55 Clinical Outcome 55 Beta Blocker 55 HAMD 55 Bronchiectasis 55 QIDS SR 55 Subtypes 55 Prolongs Survival 55 Hopkins Symptom Checklist 55 Cognitive Dysfunction 55 Carotid Artery Stenting 55 SF #v# 55 Functioning Scale 55 Pulsatile 55 Pharmacodynamic 55 Disord 55 Status Scale EDSS 55 Percutaneous Tibial Nerve Stimulation 55 Sleep Disturbance 55 Endometrial Cancer 55 Ischemic Stroke 55 imipramine Tofranil 55 Respiratory Virus 55 Somnolence 55 Meta Analysis 55 Severity MSCS score 55 Adverse Event 55 Tyrosine Kinase Inhibitor 55 Pediatric Patients 55 Preimplantation 55 Chronic Bronchitis 55 Score DAS 55 Brief Psychiatric 55 Lower Limb 55 Esophageal 55 transcranial Doppler ultrasound 55 Mortality Risk 55 Arrhythmogenic 55 Acute Physiology 55 Non Responders 55 Generalized Anxiety Disorder 55 Suicidality 55 Thromboembolic 55 Attenuation 55 Urinary Tract Infections 55 Depression Scale 55 Improves Outcomes 54 Antiviral Therapy 54 Diagnostic Criteria 54 Relapsing Remitting Multiple Sclerosis 54 cytomegalovirus infection 54 cough dyspnea 54 metastatic malignant 54 Symptom severity 54 Rheumatoid 54 Pharmacodynamics 54 Neuroprotection 54 Single Dose 54 Hemodynamic 54 Erythema 54 Nonalcoholic Fatty Liver Disease 54 Liver Failure 54 D Dimer 54 Non Alcoholic Steatohepatitis 54 Neuropsychiatric Inventory 54 Clinical Efficacy 54 Oxygen Saturation 54 Ischemic 54 Hyperlipidemia 54 Ejection Fraction 54 Clinical Practice Guideline 54 FDA Approvals 54 Adjuvant Therapy 54 Microalbuminuria 54 Dyspepsia 54 Demonstrates Significant 54 Stimulation Therapy 54 subscale scores 54 Crohn Disease Activity 54 Left Ventricular 54 Demonstrates Efficacy 54 Erosive Esophagitis 54 Visual Analogue Scale 54 Tiotropium 54 C Reactive Protein 54 Oral Fingolimod 54 Subtype 54 Interferon Alfa 54 Therapy Reduces 54 Chronic Inflammatory 54 Atopic Dermatitis 54 Lupus Erythematosus 54 Turbuhaler 54 Clinical Trial Data 54 Outcomes Study 54 Skin Irritation 54 Quotient TM 54 Postprandial 54 McGill Pain Questionnaire 54 Chemotherapy induced 54 Diabetic Neuropathy 54 Panic Disorder 54 Stent Placement 54 Reflux Disease 54 Injury Severity Score 54 Mouse Model 54 Subgroup Analysis 54 SGOT 54 Chronic Illness Therapy 54 Inhaled Corticosteroids 54 Therapy Shows Promise 54 Visual Analogue Scale VAS 54 Erythropoietic 54 Helps Relieve 54 Non Alcoholic Fatty 54 Showed Significant 54 Adjuvant Treatment 54 Clinical Significance 54 Clinician Administered PTSD 54 Orally Active 53 Heritability 53 Demonstrates Statistically Significant 53 Acute Coronary Events 53 Atomoxetine 53 Dehydrogenase 53 Gastrointestinal GI 53 bullous 53 Exhaled Nitric Oxide 53 Chronic Sinusitis 53 hyperhomocysteinemia 53 Neoplasms 53 Retreatment 53 Catheter Associated 53 Benign Prostatic Hyperplasia 53 Schizophrenia Treatment 53 Rating Scale MADRS 53 #:#-# [031] 53 Patellofemoral 53 Prospective Randomized 53 Echocardiographic 53 Diabetic Foot Ulcer 53 Pharmacogenetic 53 Investigational Treatment 53 nerve conduction velocity 53 Intracranial 53 Reduced Risk 53 Proven Effective 53 Adenomas 53 Idiopathic Pulmonary Fibrosis 53 Fasting Glucose 53 Polymorphism 53 Idiopathic 53 Lung Injury 53 Visual Analog Scale 53 BPRS 53 Oropharyngeal Candidiasis 53 Pregnancy Outcomes 53 Symptom 53 Appropriateness Criteria 53 Sclerosing 53 Kidney Function 53 Bosutinib 53 Global Impression CGI 53 Depressive Symptomatology 53 Patients Receiving 53 Community Acquired Pneumonia 53 Randomized Evaluation 53 Cutaneous 53 Erectile Function IIEF 53 HAM D# 53 icatibant 53 Inj 53 Electrophysiological 53 Chronic Renal Failure 53 aspartate aminotransferase 53 Impaired glucose tolerance 53 intraepithelial neoplasia 53 antibiotics metronidazole 53 Pain Rating Scale 53 Inflammatory Arthritis 53 Montgomery Åsberg Depression 53 Pathologic 53 Fecal Incontinence 53 Visual Analog 53 Controlled Study 53 Rhinosinusitis 53 Potent Inhibitor 53 Acute Decompensated Heart Failure 53 Eur J 53 Disease Progression 53 Initiates Clinical Trial 53 Lowers Risk 53 Virologic 53 Placebo Controlled Study 53 Transdermal Delivery 53 Combo Therapy 53 CLINICAL PHARMACOLOGY 53 Danazol 53 Obsessive Compulsive 53 abacavir Ziagen 53 International Prostate Symptom 53 dexamethasone suppression 53 FDA Clears 53 Combination Treatment 53 Study Identifies 53 CFQ R 53 Salivary 53 Guidelines Issued 53 Comorbidities 53 Genetic Marker 53 thrombocytosis 53 Reperfusion 53 Pegylated Liposomal Doxorubicin 53 Antiplatelet 53 Knee Osteoarthritis 53 Stomatitis 53 Chronic Myelogenous Leukemia 53 Lower Extremity 52 Hematocrit 52 Y BOCS 52 Captopril 52 Study Evaluating 52 HDRS 52 Iron Deficiency 52 Dose Response 52 Nucleoside 52 Non inferiority 52 Reduces Mortality 52 Test Detects 52 Parathyroid Hormone 52 Histopathologic 52 moderate hepatic impairment 52 Myalgia 52 Helps Predict 52 HADS 52 Help Predict 52 Adjunctive 52 Glomerular 52 Statistically Significant 52 Partial Nephrectomy 52 Reduces Pain 52 QoL 52 Virologic Response 52 Screening Tool 52 Heart Rate Variability 52 SGPT 52 Hamilton Rating Scale 52 Immunostimulatory 52 AST ALT 52 SLEDAI 52 Cilostazol 52 haematologic 52 Attenuated 52 Predictive Value 52 Oral Mucositis 52 Score IPSS 52 Immune Responses 52 Hemorrhagic 52 Decompensated Heart Failure 52 Non Invasive Treatment 52 Hyperparathyroidism 52 alanine aminotransferase ALT 52 HCV Infection 52 Partial Response 52 Reading Fluency 52 No Observed Adverse 52 CIAS1 52 Functional Dyspepsia 52 Protein Synthesis 52 Symptom Relief 52 Lesion 52 Stroke Scale 52 Dilated Cardiomyopathy 52 Pain Intensity 52 Insomnia Severity Index 52 SSRI citalopram 52 ACE Inhibitors 52 Dysmenorrhea 52 Chronic Heart Failure 52 ADCS CGIC 52 Potentially Fatal 52 Otitis Media 52 Comorbidity 52 QT Prolongation 52 Male Pattern Baldness 52 Secondary Hyperparathyroidism 52 Helicobacter pylori eradication 52 Endothelial Function 52 Myocardial Perfusion 52 Molecular Mechanism 52 Reductase 52 Brain Metastases 52 Inflammatory Pain 52 Fatty Liver 52 Mutational 52 NIS LL 52 Proteinuria 52 Effective Treatments 52 bivalirudin monotherapy 52 Chronic Prostatitis 52 overactive bladder syndrome 52 WAIS III 52 magnetic resonance spectroscopic imaging 52 nausea photophobia 52 Endocrinol 52 Coronary Arteries 52 Cardiotoxicity 52 Novel Inhibitor 52 Invasive Breast Cancer 52 Protease Inhibitors 52 HCV Genotype 52 Epidemiological Study 52 Keratitis 52 Global Impression 52 Cervical Spine 52 Neuropsychological 52 Study Validates 52 creatine kinase CK 52 Hypotension 52 EQ 5D 52 Phase IIa Clinical Trial 52 PEG Interferon 52 Antipsychotic 52 Myocardial Ischemia 52 Vertebral Fractures 52 treat benign prostatic 52 Renal Artery 52 Shows Statistically Significant 52 Lymphoid 52 Rapid Virologic Response 52 Immunomodulatory 52 Significantly Improved 52 Tachycardia 52 Hepatotoxicity 52 Stress Induced 52 Histologic 52 Calorimetry 52 Sexual Desire 52 subscores 52 STAI 52 Depressive Symptoms 52 Respiratory Distress 52 State Exam MMSE 52 Urine Test 52 Antiretroviral Drug 52 Decitabine 52 Prolapse 51 Psychiatric Illness 51 Drug Candidate 51 serum cortisol 51 Breast Cancer Recurrence 51 Mouth Rinse 51 Nebulized 51 Antiepileptic Drug 51 Biphasic 51 Claudication 51 dyspnoea 51 Posaconazole 51 nasal symptom 51 Platinol ® 51 Myocardial Infarction TIMI 51 elevated transaminases 51 Colorimetric 51 adrenergic receptor agonists 51 chills fever headache 51 Daptomycin 51 DAS# CRP 51 Pooled Analysis 51 WOMAC 51 Demonstrates Superior 51 Phase Ib Clinical Trial 51 Improves Survival 51 Osteomyelitis 51 Scientists Develop 51 Elderly Patients 51 Encephalomyelitis 51 bioavailable testosterone 51 Laryngeal Cancer 51 Contrast Agents 51 Strongly Linked 51 Watchful Waiting 51 Blepharospasm 51 Inflammatory Disease 51 Leukocyte 51 PARP Inhibitor 51 Stress Testing 51 Prognostic 51 Motility 51 Correlates 51 Lupus Drug 51 Depressive symptoms 51 Randomized Study 51 Shows Promise Against 51 Helps Diagnose 51 reflux esophagitis 51 Carotid Endarterectomy 51 cheilitis 51 # NNNN 51 Diagnostic Tests 51 State Trait Anxiety 51 Confirmatory 51 Irritable Bowel 51 Susceptibility Testing 51 Cardiogenic Shock 51 Immunohistochemical 51 Novel Compound 51 TRUS 51 WARFARIN 51 NDA Submission 51 Transdermal Patch 51 Allogeneic 51 Iron Deficiency Anemia 51 Angioedema 51 Abstract P# [002] 51 Lowers Blood Pressure 51 Subclinical 51 Glycosylation 51 Chronic Fatigue Syndrome CFS 51 PANSS 51 HeFH 51 Geriatric Depression 51 Infusion Reactions Severe 51 Glucose Monitor 51 Protease Inhibitor 51 ‰ ¥ 51 Hepatitis C Genotype 51 fasting plasma 51 CIN2 + 51 Ischaemic 51 Ranolazine 51 F FDG PET 51 Systemic Sclerosis 51 Electrical Stimulation 51 Critical Limb Ischemia CLI 51 Magnetic Stimulation 51 Premature Infants 51 Lupus Nephritis 51 von Willebrand Factor 51 Observational Study 51 Glomerular Filtration Rate 51 NYHA functional class 51 Anxiety Depression 51 Musculo Skeletal Disorders 51 Sleep Apnea Treatment 51 Esomeprazole 51 bronchoalveolar lavage 51 Deep Venous Thrombosis 51 Varicose 51 interobserver 51 subscore 51 Electroencephalography 51 Intervention Trial 51 Cardiac Output 51 SELENA SLEDAI 51 Nephrogenic 51 Secretion 51 Skin Lesions 51 Helps Detect 51 Anthropometric 51 Tablet Formulation 51 Sexual Satisfaction 51 Phospholipase A2 51 Alanine 51 Depression Anxiety 51 Impaired Glucose Tolerance 51 Infarct 51 Autistic Disorder 51 Stroke Scale NIHSS 51 Carcinomas 51 Bloodstream Infections 51 Hematologic 51 headache abdominal pain 51 Preterm Infants 51 Novel Oral 51 Premature Ejaculation 51 Severity Index PASI 51 Immunodeficiency 51 Hallux 51 erection hardness 51 Improves Quality 51 Moxifloxacin 51 Bronchodilator 51 Thrombocytopenia 51 Correlation Between 51 Help Detect 51 Detection Device 51 FDA Okays 51 Global Impression Severity 51 aminotransferase 51 Sleep Disturbances 51 Viral Load 50 Skin sterol 50 Atopic 50 Antidepressant Treatment 50 Demonstrated Significant 50 Intraocular Pressure 50 Antibiotic Resistant 50 Myelofibrosis 50 Liver Injury 50 Bipolar Disorders 50 cEVR 50 Hydrochloride Injection 50 Dysplasia 50 hyperreflexia 50 Prognostic Factors 50 Cystatin C 50 Mean Symptom Complex 50 Chronic Pelvic Pain 50 induce orthostatic hypotension 50 Sexual Function 50 atrioventricular block 50 comorbid anxiety 50 Reduces Risk 50 Atrial 50 acamprosate calcium 50 Heart Failure Patients 50 Study Examines 50 Respiratory Syncytial Virus RSV 50 Diabetic Nephropathy 50 Cognitive Impairment 50 Vasculitis 50 multivariate Cox 50 beta 1a 50 First Episode Psychosis 50 Quantitation 50 Study Casts Doubt 50 Alpha interferons including 50 SPRYCEL ® 50 PEGylated anti 50 Vestibular 50 depressive symptomatology 50 Generalized Anxiety Disorder GAD 50 Outcome Measures 50 Asthma Treatment 50 Implantable Cardioverter Defibrillator 50 Trigeminal Neuralgia 50 Study Sheds Light 50 Stomach Ulcer 50 Suboptimal 50 NMIBC 50 B Cell Lymphoma 50 Myeloid 50 QD dosing 50 Neuropsychiatric 50 proctitis 50 Isomer 50 State Examination MMSE 50 Proliferative 50 Prostate Specific Antigen 50 Acute Respiratory 50 Blood Glucose 50 YMRS 50 subscales 50 Levels Linked 50 Hypertensive Patients 50 Study Shows Significant 50 Short Stature 50 Antibiotic Therapy 50 selective agonist 50 hepatic cirrhosis 50 triiodothyronine 50 Primary Pulmonary Hypertension 50 Proves Effective 50 Antihistamine 50 Lipoprotein 50 Is Well Tolerated 50 interrater 50 Enzyme Replacement Therapy 50 HOMA IR 50 Luminex xTAG 50 Data Indicate 50 Ventricular Tachycardia 50 Prevent Stroke 50 Neuropathic 50 Drug Shows Promise 50 Pulmonary Artery 50 Postherpetic Neuralgia 50 Index CDAI 50 reflux disease GERD 50 Myelodysplastic Syndrome MDS 50 Systemic Lupus Erythematosus 50 Valvular 50 Alzheimer Disease Assessment 50 Montgomery Asberg Depression 50 pericardial effusion 50 Digit Symbol Substitution 50 See CLINICAL PHARMACOLOGY 50 Multicenter 50 fluconazole resistant 50 Erectile 50 Cellular Immunotherapy 50 myeloperoxidase 50 Renal Disease 50 Predict Response 50 Histological 50 demyelinating 50 Hormone Refractory Prostate Cancer 50 Exacerbations 50 Therapy Improves 50 Coronary Artery Calcium 50 TNF Tumor Necrosis Factor 50 leukocyte counts 50 Cell Proliferation 50 Hyperkalemia 50 Retinopathy 50 Restless Legs 50 Epworth Sleepiness Scale 50 Cytotoxicity 50 Synthase 50 Uterine 50 Muscle Pain 50 Severe Asthma 50 ALT elevations 50 Cognitive Function 50 Neuropsychiatric Inventory NPI 50 PANSS Positive 50 Topical Treatment 50 Fibrinogen 50 enterococcal 50 Desvenlafaxine Succinate 50 Sleepiness 50 hemorrhagic cystitis 50 Inflammatory Markers 50 FluCAM arm 50 Gastroesophageal Reflux Disease 50 diabetic polyneuropathy 50 Eye Infections 50 Psoriasis Area 50 FDA Approves Drug 50 Analytical Tool 50 Subarachnoid hemorrhage 50 penicillin G benzathine 50 Predict Dementia 50 Fibrosis 50 Acute Renal Failure 50 eosinophilia 50 Dilatation 50 Interpersonal Psychotherapy 50 Axillary 50 urothelial carcinoma 50 Neurogenic 50 Excretion 50 Iron Overload 50 Seattle Angina Questionnaire 50 Cardiovascular Disease Risk 50 FACIT Fatigue 50 Moderate Complexity 50 OSDI 50 tissue oxygenation 50 Asymptomatic 50 Androgen Receptor 50 Univariate 50 apnea hypopnea 50 Hippocampal 50 Asthma COPD 50 Surgical Procedures 50 Genetic Variation 50 preoperative PSA 50 Intravenous Infusion 50 Therapeutic Intervention 50 Cytogenetic 50 Can Predict 50 Monotherapy 50 Receptor Antagonist 50 Growth Hormone Deficiency 49 LAMICTAL 49 Usefulness 49 Renal Insufficiency 49 hematological parameters 49 GH deficiency 49 Systemic Lupus Erythematosus SLE 49 Apolipoprotein B 49 Combination Therapy 49 Nonspecific 49 Phase 2b Trial 49 Lymphocytic 49 Low Dose 49 RT PCR assay 49 Progenitor Cells 49 Osteoporosis Treatment 49 Impact Questionnaire 49 Hormone Receptor Positive 49 diabetes mellitus DM 49 Am Soc Nephrol 49 Intravascular 49 Thrombus 49 Renal Function 49 Index WOMAC 49 Insulin Resistance 49 Demyelinating 49 Can Detect 49 Spasticity 49 Obese Patients 49 APACHE II 49 artery stenosis 49 Inventory BPI 49 Septic Shock 49 UPDRS 49 Nephropathy 49 Bosentan 49 Genes Associated 49 Prognostic Value 49 HER2 overexpressing 49 Exercise Induced 49 Newly Identified 49 Ankle Brachial Index 49 Solid Tumors 49 Follicular Lymphoma 49 Glycoprotein 49 psychometric properties 49 Nosocomial 49 idiopathic thrombocytopenic purpura ITP 49 Contraindications 49 nimodipine 49 Inhaled Nitric Oxide 49 Platelet Function 49 Hepatitis B Virus 49 Skin Disorders 49 Encephalopathy 49 Beta Blockers 49 Stable Angina 49 neutropaenia 49 Pemphigus 49 Facial Skin 49 Thiazolidinediones 49 Estrogen Receptor 49 mucosal inflammation 49 erythrocyte sedimentation rate 49 Cytometry 49 chronic urticaria 49 antigen PSA levels 49 TR ETN NYSE 49 serum sodium levels 49 Cholinesterase Inhibitors 49 nausea somnolence 49 Suppositories 49 coronary stenosis 49 Major Depressive Disorder MDD 49 Node Negative 49 Severity 49 Inflammatory Response 49 â ‰ ¥ 49 Nilotinib 49 Acidosis 49 Adjunctive Therapy 49 IBDQ 49 liver histology 49 HRQL 49 Bone Metabolism 49 Maslach Burnout Inventory 49 Small Bowel 49 somatostatin analog 49 PEGylated interferon beta 1a 49 CDAI 49 TNSS 49 Receptor Antagonists 49 Slow Progression 49 serum prostate 49 Bioequivalence 49 Uric Acid 49 Rheumatoid Arthritis Patients 49 Protease 49 Target Lesion Revascularization TLR 49 Menstrual Pain 49 humanized monoclonal 49 Verbal Learning 49 Ureteral 49 -#.# ± [002] 49 Oxidative 49 Non Inferiority 49 JAK Inhibitor 49 BMI z 49 MCyR 49 Helps Prevent 49 IgA Nephropathy 49 Carotid 49 paresthesias 49 Oral Formulation 49 murine model 49 Unfractionated Heparin 49 r2 = 49 T2DM 49 Medication Adherence 49 Retinal Vein Occlusion 49 Pelvic Organ Prolapse 49 Nucleic Acid Amplification 49 CIMZIA TM certolizumab pegol 49 Severe Acute 49 Chronic Lymphocytic Leukemia 49 Pathogenesis 49 Malformations 49 See WARNINGS 49 Interstitial Cystitis 49 Immunosuppression 49 IDDM 49 Patients Suffering 49 Valvular Heart Disease 49 Abdominal Fat 49 Musculoskeletal Disorders 49 Infarction 49 eNO 49 Diabetic Neuropathy DN 49 Differential diagnosis 49 Cardiac Function 49 Often Misdiagnosed 49 MAXALT 49 Onychomycosis 49 Childhood Trauma 49 Parainfluenza 49 Brain Function 49 leukoencephalopathy 49 Hypertriglyceridemia 49 Researchers Uncover 49 Assay Kit 49 transthyretin TTR mediated amyloidosis 49 Arch Intern Med 49 Mass Spectrometers 49 Cytotoxic 49 Elastography 49 Secretory 49 Proves Successful 49 Inhibits 49 Nutritional Status 49 #:# -# [004] 49 ADAS cog 49 ADHD Rating Scale 49 Infectivity 49 Syncope 49 Helps Identify 49 Cystic Fibrosis Questionnaire Revised 49 bacillus Calmette Guerin 49 Index FSFI 49 Mechanical Ventilation 49 Fibroblast 49 Further Validates 49 Negative Syndrome 49 Soft Tissue Sarcoma 49 Amplicor 49 Maleate 49 gastroduodenal 49 Abrupt discontinuation 49 Receptor Agonist 49 Medication Errors 49 Dose Reduction 49 CP CPPS 49 rhinorrhea 49 Safinamide 49 Phase 2b Study 49 Viral Infection 49 sulfonamide 49 Clinical Relevance 49 RECIST Response Evaluation Criteria 49 lipid elevations 49 Genetic Tests 49 Vertebral Augmentation 49 Transthyretin 49 Sinus Infections 49 Chronic Insomnia 49 Platelet Aggregation 49 Inhibitory 49 Phosphatase 49 Depression Rating Scale 49 cTnI 49 Brain Shrinkage 49 Cerebrospinal Fluid 49 Signaling Pathways 49 Adalimumab 49 Oncolytic 49 Hemolytic 49 QVAR ® 49 MMSE 48 autonomic dysfunction 48 urinary N telopeptide 48 spirometric 48 Braunwald E. 48 Pharmacoeconomic 48 Tumor Markers 48 Diagnostic Interview CIDI 48 Secondary Endpoints 48 symptom severity 48 CIBIC plus 48 dysuria 48 immunostaining 48 EP4 48 Fibromyalgia Pain 48 erosive gastritis 48 interrater reliability 48 Adiposity 48 Malignant Glioma 48 Muscle Wasting 48 Comorbid 48 transaminase 48 Gastroparesis 48 Complicated Skin 48 Mammographic 48 hypophosphatemia 48 mcg QD 48 Apnea 48 Posttraumatic 48 urinary iodine 48 Prostate Cancer Risk 48 idiopathic Parkinson disease 48 Novel Mechanism 48 Clin J 48 Continence Society 48 Breast Tissue 48 Socioeconomic Status 48 Extracellular 48 Numoisyn Liquid 48 erythematosus 48 Fasting plasma glucose 48 Glucose Metabolism 48 Diabetic Retinopathy 48 Postoperative 48 LPS induced 48 Contrast Agent 48 uricase 48 Aridol TM 48 Hypertrophic 48 Neurofibromatosis Type 48 Cinacalcet